Related Experiment Videos
[Gentamycin dosage interval in premature infants]
Tijdschrift Voor Kindergeneeskunde
|April 1, 1984
Summary
Administering gentamicin every 18 hours, instead of every 12 hours, significantly reduces elevated serum concentrations in preterm infants. This dosing interval is recommended for neonates to improve gentamicin safety.
Area of Science:
- Neonatal pharmacology
- Pediatric pharmacokinetics
- Antibiotic dosing optimization
Context:
- Gentamicin is a critical antibiotic for treating serious infections in neonates.
- Preterm infants (<35 weeks gestational age) exhibit altered drug metabolism and excretion.
- Maintaining therapeutic gentamicin levels while minimizing toxicity is essential.
Purpose:
- To evaluate the impact of different intravenous gentamicin dose intervals on serum concentrations in preterm neonates.
- To determine the optimal dosing interval to prevent sub-therapeutic and toxic gentamicin levels in the first week of life.
Summary:
- A study compared gentamicin (2.5 mg/kg) administered every 12 hours versus every 18 hours in preterm infants.
- Elevated pre-dose gentamicin serum concentrations (>2.0 microgram/ml) were observed in 53% of infants on the 12-hour interval, compared to 27% on the 18-hour interval (p<0.01).
- The 18-hour interval demonstrated a significantly lower incidence of elevated gentamicin levels.
Impact:
- The findings support an 18-hour dosing interval for gentamicin (2.5 mg/kg) in preterm infants during the first postnatal week.
- This adjustment may improve the safety profile of gentamicin therapy in this vulnerable population.
- Continued therapeutic drug monitoring of gentamicin serum levels remains crucial despite optimized dosing.